CAS: 1130067-06-9
VU0155069
CAS:1130067-06-9
Formula:
C26H28Cl2N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
499.4321
Ref: IN-DA0081MP
| 1mg | 72.00 € | ||
| 5mg | 154.00 € | ||
| 10mg | 242.00 € | ||
| 25mg | 537.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 54-BISN0085
| 1mg | 42.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
![(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-nap…](https://static.cymitquimica.com/products/10/thumb/F544995.jpg)
(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide
CAS:1130067-06-9
Purity:
98.0%
Molecular weight:
498.158931496
Ref: 10-F544995
| 1mg | To inquire |
Estimated delivery in United States, on Thursday 19 Dec 2024
VU-0155069
CAS:1130067-06-9
VU-0155069 is a small molecule that inhibits fatty acid uptake and metabolism in the kidney. …
Formula:
C26H27ClN4O2
Purity:
Min. 95%
Molecular weight:
462.97 g/mol
Ref: 3D-FVB06706
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
VU0155069
CAS:1130067-06-9
VU0155069, a selective PLD1 inhibitor (IC50: 46 nM), halts cancer cell migration in transwell assays.
Formula:
C26H27ClN4O2
Purity:
98.32%
Color and Shape:
Solid
Molecular weight:
462.97
Ref: TM-T17239
| 2mg | 41.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 93.00 € | ||
| 25mg | 182.00 € | ||
| 50mg | 320.00 € | ||
| 100mg | 546.00 € | ||
| 1mL*10mM (DMSO) | 61.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
